Evolution from acute Q fever to endocarditis is associated with underlying valvulopathy and age and can be prevented by prolonged antibiotic treatment

Clinical Infectious Diseases

Volumn 57, Issue 6, 2013, Pages 836-844

  Million, Matthieu ^a   Walter, Gaëlle ^a   Thuny, Franck ^a,b,c   Habib, Gilbert ^b   Raoult, Didier ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

^b TIMONE HOSPITAL   (France)

^c HÔPITAL NORD   (France)

Author keywords

age; antibiotic prophylaxis; heart valve disease; prevention; Q fever endocarditis

Indexed keywords

DOXYCYCLINE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; AGE DISTRIBUTION; AGED; ANTIBIOTIC PROPHYLAXIS; AORTA VALVE REGURGITATION; ARTICLE; BACTERIAL ENDOCARDITIS; COHORT ANALYSIS; DISEASE ASSOCIATION; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MITRAL VALVE REGURGITATION; PRIORITY JOURNAL; Q FEVER; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSTHORACIC ECHOCARDIOGRAPHY; TREATMENT DURATION; VALVULAR HEART DISEASE;

AGE; ANTIBIOTIC PROPHYLAXIS; HEART VALVE DISEASE; PREVENTION; Q FEVER ENDOCARDITIS;

ADULT; AGE FACTORS; AGED; ANTI-BACTERIAL AGENTS; ANTIBIOTIC PROPHYLAXIS; ECHOCARDIOGRAPHY, TRANSESOPHAGEAL; ENDOCARDITIS, BACTERIAL; FEMALE; HEART VALVE DISEASES; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; Q FEVER; RISK FACTORS;

EID: 84883244399     PISSN: 10584838     EISSN: 15376591     Source Type: Journal    
DOI: 10.1093/cid/cit419     Document Type: Article

References (35)

1. Maurin M, Raoult D. Q fever. Clin Microbiol Rev 1999; 12:518-53.
2. Hogema BM, Slot E, Molier M, et al. Coxiella burnetii infection among blood donors during the 2009 Q-fever outbreak in the Netherlands. Transfusion 2012; 52:144-50.
3. Tissot-Dupont H, Vaillant V, Rey S, Raoult D. Role of sex, age, previous valve lesion, and pregnancy in the clinical expression and outcome of Q fever after a large outbreak. Clin Infect Dis 2007; 44:232-7.
4. Van Der Hoek W, Versteeg B, Meekelenkamp JC, et al. Follow-up of 686 patients with acute Q fever and detection of chronic infection. Clin Infect Dis 2011; 52:1431-6.
5. Fenollar F, Fournier PE, Carrieri MP, Habib G, Messana T, Raoult D. Risks factors and prevention of Q fever endocarditis. Clin Infect Dis 2001; 33:312-6.
6. Leroy Q, Armougom F, Barbry P, Raoult D. Genomotyping of Coxiella burnetii using microarrays reveals a conserved genomotype for hard tick isolates. PLoS One 2011; 6:e25781.
7. Mogollon MV, Anguita MP, Aguado JM, et al.; Q fever endocarditis in Spain. Clinical characteristics and outcome. Enferm Infecc Microbiol Clin 2011; 29:109-16.
8. Million M, Thuny F, Richet H, Raoult D. Long-term outcome of Q fever endocarditis: a 26-year personal survey. Lancet Infect Dis 2010; 10:527-35.
9. Raoult D, Tissot-Dupont H, Foucault C, et al. Q fever 1985-1998. Clinical and epidemiologic features of 1,383 infections. Medicine (Baltimore) 2000; 79:109-23.
10. Fenollar F, Thuny F, Xeridat B, Lepidi H, Raoult D. Endocarditis after acute Q fever in patients with previously undiagnosed valvulopathies. Clin Infect Dis 2006; 42:818-21.
11. Raoult D, Million M, Thuny F, Carrieri P. Chronic Q fever detection in the Netherlands. Clin Infect Dis 2011; 53:1170-1.
12. Houpikian P, Habib G, Mesana T, Raoult D. Changing clinical presentation of Q fever endocarditis. Clin Infect Dis 2002; 34:E28-31.
13. Raoult D. Chronic Q fever: expert opinion versus literature analysis and consensus. J Infect 2012; 65:102-8.
14. Lancellotti P, Tribouilloy C, Hagendorff A, et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 1: aortic and pulmonary regurgitation (native valve disease). Eur J Echocardiogr 2010; 11:223-44.
15. Kampschreur LM, Dekker S, Hagenaars JC, et al. Identification of risk factors for chronic Q fever, the Netherlands. Emerg Infect Dis 2012; 18:563-70.
16. Kampschreur LM, Hagenaars JC,Wielders CC, et al. Screening for Coxiella burnetii seroprevalence in chronic Q fever high-risk groups reveals the magnitude of the Dutch Q fever outbreak. Epidemiol Infect 2013; 141:847-51.
17. Dupuis G, Peter O, Pedroni D, Petite J. Clinical aspects observed during an epidemic of 415 cases of Q fever [in French]. Schweiz Med Wochenschr 1985; 115:814-8.
18. Duval X, Alla F, Hoen B, et al. Estimated risk of endocarditis in adults with predisposing cardiac conditions undergoing dental procedures with or without antibiotic prophylaxis. Clin Infect Dis 2006; 42: e102-7.
19. Maltezou HC, Constantopoulou I, Kallergi C, et al. Q fever in children in Greece. Am J Trop Med Hyg 2004; 70:540-4.
20. Diagnosis and management of Q fever-United States, 2013: recommendations from CDC and the Q Fever Working Group. MMWR Recomm Rep 2013; 62(RR-03):1-30.
21. Derrick EH. The course of infection with Coxiella burnetii. Med J Aust 1973; 1:1051-7.
22. Dijkstra F, Van Der Hoek W, Wijers N, et al. The 2007-2010 Q fever epidemic in the Netherlands: characteristics of notified acute Q fever patients and the association with dairy goat farming. FEMS Immunol Med Microbiol 2012; 64:3-12.
23. Iung B, Baron G, Tornos P, Gohlke-Barwolf C, Butchart EG, Vahanian A. Valvular heart disease in the community: a European experience. Curr Probl Cardiol 2007; 32:609-61.
24. Lamas CC, Eykyn SJ. Bicuspid aortic valve-a silent danger: analysis of 50 cases of infective endocarditis. Clin Infect Dis 2000; 30:336-41.
25. Edouard S, Mahamat A, Demar M, Abboud P, Djossou F, Raoult D. A comparison between emerging Q fever in French Guiana and endemic Q fever in Marseille, France. Am J Trop Med Hyg 2013. In press.
26. Kampschreur LM, Delsing CE, Groenwold RHH, et al. Chronic Q fever in the Netherlands five years after the start of the Q fever epidemic: results from the Dutch Chronic Q Fever Database. In: Gildeprint Drukkerijen, Enschede, ed. Chronic Q fever in the Netherlands. 2013:133-46.
27. Frankel D, Richet H, Renvoise A, Raoult D. Q fever in France, 1985-2009. Emerg Infect Dis 2011; 17:350-6.
28. Stein A, Raoult D. Lack of pathotype specific gene in human Coxiella burnetii isolates. Microb Pathog 1993; 15:177-85.
29. Glazunova O, Roux V, Freylikman O, et al. Coxiella burnetii genotyping. Emerg Infect Dis 2005; 11:1211-7.
30. Mahamat A, Edouard S, Demar M, et al. A unique clone of Coxiella burnetii associated with the emergence of Q fever in French Guiana. Emerg Infect Dis. 2013; 19:1102-4.
31. Angelakis E, Million M, D'Amato F, et al. Q fever and pregnancy: disease, prevention, and strain specificity. Eur J Clin Microbiol Infect Dis 2013; 32:361-8.
32. Huijsmans CJ, Schellekens JJ, Wever PC, et al. Single- nucleotidepolymorphism genotyping of Coxiella burnetii during a Q fever outbreak in the Netherlands. Appl Environ Microbiol 2011; 77:2051-7.
33. Million M, Raoult D. Acute Q fever, endocarditis and IgG anticardiolipin antibodies [Epub ahead of print]. N Engl J Med 2013.
34. Million M, Walter G, Bardin N, et al. IgG anticardiolipin antibodies and progression to Q fever endocarditis. Clin Infect Dis 2013; 57:836-44.
35. Hartzell JD, Gleeson T, Scoville S, Massung RF, Wortmann G, Martin GJ. Practice guidelines for the diagnosis and management of patients with Q fever by the Armed Forces Infectious Diseases Society. Mil Med 2012; 177:484-94.